{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:29:10Z","timestamp":1749634150740},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1007\/bf02235184","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T10:06:00Z","timestamp":1129889160000},"page":"66-70","source":"Crossref","is-referenced-by-count":7,"title":["Human leukocyte antigens as genetic markers in colorectal carcinoma"],"prefix":"10.1097","volume":"42","author":[{"given":"M. A.","family":"Chatzipetrou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. E.","family":"Tarassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Konstadoulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. E.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Zafirellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. E.","family":"Athanassiades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. G.","family":"Panousopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. C.","family":"Golematis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Papasteriades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"BF02235184_CR1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1097-0142(19890401)63:7<1318::AID-CNCR2820630716>3.0.CO;2-R","volume":"63","author":"F Juhasz","year":"1989","unstructured":"Juhasz F, Boros P, Szegedi G, et al. Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer 1989;63:1318\u201326.","journal-title":"Cancer"},{"key":"BF02235184_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1399-0039.1994.tb02341.x","volume":"43","author":"D Rigopoulou","year":"1994","unstructured":"Rigopoulou D, Martinez-Laso J, Martinez-Tello F, et al. Both class I and class II HLA antigens are thyroid cancer susceptibility factors. Tissue Antigens 1994;43:281\u20135.","journal-title":"Tissue Antigens"},{"key":"BF02235184_CR3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/352723a0","volume":"352","author":"R Wank","year":"1991","unstructured":"Wank R, Thomsen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQW3. Nature 1991;352:723\u20135.","journal-title":"Nature"},{"key":"BF02235184_CR4","first-page":"4276","volume":"42","author":"BO Barger","year":"1982","unstructured":"Barger BO, Acton RT, Soong SJ, Roseman J, Balch C. Increase of HLA-DR4 in melanoma patients from Alabama. Cancer Res 1982;42:4276\u20139.","journal-title":"Cancer Res"},{"key":"BF02235184_CR5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ijc.2910590413","volume":"59","author":"JE Lee","year":"1994","unstructured":"Lee JE, Reveille JD, Ross MI, Platsoucas CD. HLA-DQB1*0301 association with increased cutaneous melanoma risk. Int J Cancer 1994;59:510\u20133.","journal-title":"Int J Cancer"},{"key":"BF02235184_CR6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/1097-0142(19910815)68:4<916::AID-CNCR2820680440>3.0.CO;2-R","volume":"68","author":"C Kratzik","year":"1991","unstructured":"Kratzik C, Aiginger P, Kuber W, et al. Risk factors for bilateral testicular germ cell tumors. Cancer 1991;68:916\u201321.","journal-title":"Cancer"},{"key":"BF02235184_CR7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3109\/02841869409098467","volume":"33","author":"A Sory","year":"1994","unstructured":"Sory A, Gorski A, Misiuna P, Wallner G, Polkowski W. Is gastric cancer heterogeneity the clue to HLA-DR associated susceptibility? Acta Oncol 1994;33:976\u20137.","journal-title":"Acta Oncol"},{"key":"BF02235184_CR8","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/1097-0142(19900915)66:6<1154::AID-CNCR2820660613>3.0.CO;2-3","volume":"66","author":"DA Hilton","year":"1990","unstructured":"Hilton DA, West KP. An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma. Cancer 1990;66:1154\u20137.","journal-title":"Cancer"},{"key":"BF02235184_CR9","first-page":"280","volume":"37","author":"VI Levin","year":"1991","unstructured":"Levin VI, Muravskaia GV, Buglova EE, et al. The distribution of HLA-system antigens in lung cancer patients. Vopr Onkol 1991;37:280\u20133.","journal-title":"Vopr Onkol"},{"key":"BF02235184_CR10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/02841869109092420","volume":"30","author":"M Toumbis","year":"1991","unstructured":"Toumbis M, Zervas J, Anagnostopoulou O, et al. HLA antigens and bronchogenic carcinoma in the Greek population. Acta Oncol 1991;30:575\u20138.","journal-title":"Acta Oncol"},{"key":"BF02235184_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1983.tb00707.x","volume":"70","author":"RL Dawkins","year":"1983","unstructured":"Dawkins RL, Christiansen FT, Kay PH, et al. Disease associations with complotypes, supratypes, and haplotypes. Immunol Rev 1983;70:5\u201322.","journal-title":"Immunol Rev"},{"key":"BF02235184_CR12","first-page":"8","volume":"45","author":"PA Wingo","year":"1995","unstructured":"Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA;1995;45:8\u201330.","journal-title":"CA"},{"key":"BF02235184_CR13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/1097-0142(19920901)70:3+<1300::AID-CNCR2820701517>3.0.CO;2-O","volume":"70","author":"HT Lynch","year":"1992","unstructured":"Lynch HT, Watson P, Smyrk TC, et al. Colon cancer genetics. Cancer Suppl 1992;70:1300\u201312.","journal-title":"Cancer Suppl"},{"key":"BF02235184_CR14","first-page":"1","volume-title":"Management of gastrointestinal diseases","author":"SJ Winawer","year":"1992","unstructured":"Winawer SJ, Enker WE, Levin B. Colorectal cancer. In: Winawer SJ (ed) Management of gastrointestinal diseases. New York: Gower Medical Publishing, 1992;27:1\u201340."},{"key":"BF02235184_CR15","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/1097-0142(19871101)60:9<2355::AID-CNCR2820600940>3.0.CO;2-R","volume":"60","author":"P Rozen","year":"1987","unstructured":"Rozen P, Lynch HT, Figer A, et al. Familial colon cancer in the Tel-Aviv area and the influence of ethnic origin. Cancer 1987;60:2355\u20139.","journal-title":"Cancer"},{"key":"BF02235184_CR16","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM198506133122403","volume":"312","author":"RW Burt","year":"1985","unstructured":"Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH. Dominant inheritance of adenomatous colonic polyps and colorectal cancer. N Engl J Med 1985;312:1540\u20134.","journal-title":"N Engl J Med"},{"key":"BF02235184_CR17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM198809013190902","volume":"319","author":"LA Cannon-Albright","year":"1988","unstructured":"Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med 1988;319:533\u20137.","journal-title":"N Engl J Med"},{"key":"BF02235184_CR18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/204998b0","volume":"204","author":"PI Terasaki","year":"1964","unstructured":"Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204:998\u20131000.","journal-title":"Nature"},{"key":"BF02235184_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1399-0039.1986.tb00500.x","volume":"28","author":"F Vartdal","year":"1986","unstructured":"Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation\u2014a fast and reliable technique. Tissue Antigens 1986;28:301\u201312.","journal-title":"Tissue Antigens"},{"key":"BF02235184_CR20","first-page":"939","volume":"4","author":"A Yagita","year":"1977","unstructured":"Yagita A, Abe O, Sekiguchi S. HLA type in patients with colon and rectum cancer and ulcerative colitis with special reference to cancer susceptibility [in Japanese]. Cancer Chemother 1977;4:939\u201345.","journal-title":"Cancer Chemother"},{"key":"BF02235184_CR21","first-page":"138","volume":"2","author":"B Sakellariou","year":"1985","unstructured":"Sakellariou B, Mavroyannis C, Kapellou P, et al. HLA-A,B antigens and colorectal neoplasms [in Greek]. Arch Greek Med 1985;2:138\u201340.","journal-title":"Arch Greek Med"},{"key":"BF02235184_CR22","first-page":"443","volume":"307","author":"M Alcalay","year":"1982","unstructured":"Alcalay M, Bontoux D, Maire PH, Matuchanscky CL, Alcalay D, Tanzen J. HLA-B27 and colorectal cancer. N Engl J Med 1982;307:443\u20134.","journal-title":"N Engl J Med"},{"key":"BF02235184_CR23","first-page":"182","volume":"11","author":"D Lio","year":"1994","unstructured":"Lio D, Caccamo N, D'Anna C, et al. Viral antibody titers are influenced by HLA-DR2 phenotype. Exp Clin Immunogenet 1994;11:182\u20136.","journal-title":"Exp Clin Immunogenet"},{"key":"BF02235184_CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-0039.1995.tb02427.x","volume":"45","author":"A Kaloterakis","year":"1995","unstructured":"Kaloterakis A, Papasteriades C, Filliotou A, Economidou J, Hadjiyannis S, Stratigos J. HLA in familial and nonfamilial Mediterranean Kaposi's sarcoma in Greece. Tissue Antigens 1995;45:117\u20139.","journal-title":"Tissue Antigens"},{"key":"BF02235184_CR25","first-page":"167","volume-title":"HLA antigens in Greek type I diabetics","author":"C Papasteriades","year":"1991","unstructured":"Papasteriades C, Arseniou P, Bicas N, Ioannides G, Thalassinos N. HLA antigens in Greek type I diabetics. 11th International Histocompatibility Workshop and Conference. Yokohama, Book of Abstracts, Nishimura H, Sasazuki T (eds), Kyushu University, Fukuoka, Japan 1991;167."},{"key":"BF02235184_CR26","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1073\/pnas.88.6.2598","volume":"88","author":"P Salgame","year":"1991","unstructured":"Salgame P, Convit J, Bloom BR. Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted. Proc Natl Acad Sci USA 1991;88:2598\u2013602.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Diseases of the Colon &amp; Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1007\/BF02235184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T16:51:56Z","timestamp":1620924716000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003453-199942010-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999]]}},"URL":"https:\/\/doi.org\/10.1007\/bf02235184","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}